A phase II, randomized, double-blind, placebo controlled, multi-center study to evaluate the effects of LCI699 on cortisol in patients with hypertension

Update Il y a 4 ans
Reference: EUCTR2008-007337-49

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To determine the maximum tolerated dose (MTD) of LCI699 with respect to cortisol suppression following ACTH stimulation in hypertensive patients


Inclusion criteria

  • Hypertension

Links